# Expression of Concern: WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: A phase 2, randomized, double blind, placebo controlled study

PMC · DOI: 10.1371/journal.pntd.0014047 · 2026-03-05

## Full-text entities

- **Diseases:** Tropical Diseases (MESH:D015493), Leishmania major cutaneous leishmaniasis (MESH:D016773)
- **Chemicals:** WR279,396 (-), aminoglycoside (MESH:D000617)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12962470